Immunology

A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.

The statistics are stark: People of color are vastly underrepresented in medical and scientific professions. But various programs—including ones sponsored by Johnson & Johnson—are working to help level the playing field.

For Pregnancy and Infant Loss Awareness Month, learn how one woman advocated for herself and fought to complete her family after she was diagnosed with hemolytic disease of the fetus and newborn—and why Johnson & Johnson is committed to finding a better treatment for this rare and deadly blood disorder.

A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.

Imagine reversing the course of conditions like Alzheimer’s or multiple sclerosis, in which cells of the central nervous system stop working or die. Researchers at Johnson & Johnson are hot on the trail of innovative solutions that may do just that, preventing often-debilitating symptoms along the way.

What do diseases like multiple myeloma and lupus have in common? They’re more prevalent in people of color—yet historically these patients have been left out of clinical research, often to dire health consequences. Learn how Johnson & Johnson is working to make the study of conditions like these more equitable.

Over the past few decades, advances in the study and treatment of this inflammatory bowel disease have rapidly accelerated. We spoke to the experts to learn the latest about managing Crohn’s disease—and what other potential breakthroughs are on the horizon.

Alisha Bridges once lived in shame about her chronic skin condition, which causes itchy and scaly patches. Now she’s on a mission to educate and empower others living with the autoimmune disease. For World Psoriasis Day, she’s sharing her story.

Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That’s why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.

Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.